Catalyst Biosciences downgraded by Raymond James
$CBIO
Raymond James downgraded Catalyst Biosciences from Outperform to Market Perform
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
11/15/2021 | Outperform → Market Perform | Raymond James | |
8/6/2021 | $19.00 → $18.00 | Outperform | Raymond James |
4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
4 - GYRE THERAPEUTICS, INC. (0001124105) (Issuer)
8-K - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
8-K/A - GYRE THERAPEUTICS, INC. (0001124105) (Filer)
8-K/A - GYRE THERAPEUTICS, INC. (0001124105) (Filer)